In this podcast, Jeff Jin, PhD, discusses his team's recent study, which examined the prevalence of hepatitis C virus infection among men who have sex with men.
In this podcast, Daniel Fierer, MD, from the Icahn School of Medicine at Mt. Sinai, discusses treating and managing HIV-HCV coinfection in men who have sex with men.
Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
In this podcast, Marc Ghany, MD, MHSc, discusses the recent publication of "Hepatitis C Guidance 2019 Update: AASLD‐IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus...
Jorge Herrera, MD director of the Section of Hepatology and professor of Internal Medicine at the University of South Alabama, discusses screening, referring, and managing patients...
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
Sammy Saab, MD, MPH, from the Ronald Reagan UCLA Medical Center explains the potentially deadly consequences of hepatitis B reactivation in patients being treated for hepatitis C, and why screening for...
A new study has indicated that the transplantation of HCV-positive livers into HCV-negative individuals may be a viable option in the era of direct-acting antiviral therapy. Consultant360 discussed the...
John D. Scott, MD, from UW Telehealth and the Hepatitis and Liver Clinic at Harborview Medical Center talks about the stages of and treatments for hepatitis C.
